Alexandre Bodmer
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Papers in
- Oncology 31
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 9
- PARP inhibition in cancer therapy 4
-
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 4
- Co-authors
- Khalil ZamanDavid CameronAlexey KovalVladimir L. KatanaevJiabin XuHervé BonnefoiPierre O. ChappuisÉtienne Brain
- Journals
- Annals of Oncology (6 papers)British Journal of Cancer (3 papers)Surgical Oncology (2 papers)The Breast Journal (2 papers)Cancer Research (2 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Alexandre Bodmer
44 papers receiving 687 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 259
- Oncology 344
- Pathology and Forensic Medicine 107
- Radiology, Nuclear Medicine and Imaging 105
- Genetics 47
Countries citing papers authored by Alexandre Bodmer
This map shows the geographic impact of Alexandre Bodmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Bodmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Bodmer more than expected).
Fields of papers citing papers by Alexandre Bodmer
This network shows the impact of papers produced by Alexandre Bodmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Bodmer. The network helps show where Alexandre Bodmer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexandre Bodmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 17 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 72 | |
| 11 | 2019 | 13 | |
| 12 | 2019 | 16 | |
| 13 | 2017 | 6 | |
| 14 | 2014 | 56 | |
| 15 | 2014 | 19 | |
| 16 | 2012 | 8 | |
| 17 | 2011 | 12 | |
| 18 | 2011 | 9 | |
| 19 | 2009 | 4 | |
| 20 | 2001 | 10 |
About Alexandre Bodmer
Alexandre Bodmer is a scholar working on Oncology, Cancer Research, Dermatology, Internal Medicine and Endocrinology, having authored 49 papers that have together received 692 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (8 papers), BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers), PARP inhibition in cancer therapy (4 papers), Estrogen and related hormone effects (4 papers) and Breast Lesions and Carcinomas (4 papers). The work is most often cited by research in Cancer Research (259 citations), Oncology (344 citations), Pathology and Forensic Medicine (107 citations), Radiology, Nuclear Medicine and Imaging (105 citations) and Genetics (47 citations). Alexandre Bodmer has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Khalil Zaman, David Cameron, Alexey Koval, Vladimir L. Katanaev, Jiabin Xu, Hervé Bonnefoi, Pierre O. Chappuis, Étienne Brain, Cosmin Moldovan and Olivier Trédan. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Surgical Oncology, The Breast Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.